YPEL3 and nasopharyngeal carcinoma: In nasopharyngeal cancer cells, YPEL3 promotes E-cadherin expression by inhibiting the entry of β-catenin into the nucleus, and inhibits vimentin expression to regulate the EMT process, YPEL3 also inhibits cell proliferation and migration [20].